Agenda

Agenda
Thursday, November 2, 2023
Times are in pacific standard time zone.

3:00 PM Registration and Exhibits
3:25 PM Welcome Remarks

SESSION 1: AI Diagnostics
3:00 PM GA progression with AI
Ursula Schmidt-Erfurth, MD
3:05 PM Diabetic retinopathy screening
Jennifer Lim, MD
3:10 PM AI in vitreoretinal Surgery
Yannek I. Leiderman, MD
3:15 PM Panel Discussion
Moderators: Theodore Leng, MD, FACS and Daniel Ting, MBBS (Hons), M Med(Ophth)

SESSION 2: Is Complement Inhibition Overrated?
3:30 PM Inflammation: is it real and will it harm patients
Sunil Srivastava, MD
3:35 PM Real world experience with complement inhibition
Dante Pieramici, MD
3:40 PM Emerging complement targets and delivery
Peter Kaiser, MD
3:45 PM Safety reporting for ocular therapies
Judy Kim. MD
3:50 PM Panel Discussion
Moderators: Diana Do, MD and Eleonora M. Lad, MD, PhD

SESSION 3: New Targets? Better Drugs? Better Delivery?
4:05 PM Non-intravitreal delivery
Michael Singer, MD
4:10 PM Just an eye drop: Topical delivery technologies
Arshad M. Khanani, MD
4:15 PM Biosimilars in today’s practice enviroment
David M. Brown, MD
4:20 PM Economics of biosimilars: The good and bad
Ravi Parikh, MD, PhD
4:25 PM Panel Discussion: Biosimilars are here, now what?
Moderators: Baruch D. Kuppermann and Prithvi Mruthyunjaya MD, MHS

4:40 PM Break and Exhibits

SESSION 4: Young Innovators Forum (NON-CE)
5:10 PM The academic career: Feeding innovation into industry
Mark S. Blumenkranz, M.D., MMS
5:15 PM The Private practice career: Driving innovation through clinical research
David Eichenbaum, MD
5:20 PM Climbing the ladder in Industry: Where to go next
Thomas Ciulla, MD
5:25 PM Is there still a role to be a surgical innovator?
Ramin Tadayoni, MD
5:30 PM Panel Discussion: Defining a career outside the retina operating room
Moderators: Stephen Smith, MD and Darius M. Moshfeghi, MD

SESSION 5: Impending Innovations in Angiogenesis (NON-CE)
5:45 PM Unlimited durability: How long is enough
Philip Rosenfeld, MD
5:50 PM Non-VEGF strategies: Promise or bust?
David Boyer, MD
5:55 PM Gene therapy solutions
Lejla Vajzovic, MD
6:00 PM TBD
6:05 PM Panel Discussion: Challenges in future clinical trial design
Moderator: Robert Bhisitkul, MD, PhD and Quan Dong Nguyen, MD, MSc
6:30 PM Concludes